Lars H. Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lars H. Nelson has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn M. Lenz
Department of Psychology, The Ohio State University, Columbus, USA
5 shared publications - Colin J. Saldanha
American University
2 shared publications Alyssa L. Pedersen
Department of Biology, Behavior, Cognition, and Neuroscience Program and The Center for Behavioral Neuroscience, American University, Washington, DC 20016
1 shared publicationAmy W. Lasek
Department of Pharmacology and Toxicology, Virginia Commonwealth University, PO Box 980613, Richmond, VA, 23298, USA
1 shared publicationAngela I. Saulsbery
Department of Psychology, The Ohio State University, Columbus, OH 43210, USA
1 shared publicationCarissa J. Mehos
Department of Biology and Center for Behavioral Neuroscience American University Washington DC USA
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Elsevier in Neuropharmacology
- Vol. 299, 111086
Loss of mGlu5 receptors from PV inhibitory neurons attenuates sex differences in ethanol and sucrose seeking
- 1 July 2026
- Published by Elsevier in Neuropharmacology
- Vol. 299, 111086
Open AccessLoss of mGlu5 receptors from PV inhibitory neurons attenuates sex differences in ethanol and sucrose seeking
- 1 May 2019
- Published by Elsevier in Progress in Neurobiology
- Vol. 176, 103-119
Small cells with big implications: Microglia and sex differences in brain development, plasticity and behavioral health
- 1 May 2019
- Published by Elsevier in Progress in Neurobiology
- Vol. 176, 103-119
Small cells with big implications: Microglia and sex differences in brain development, plasticity and behavioral health
- Top Cited PapersOpen Access
- 13 April 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 698
Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function
Innate immune cells play a well-documented role in the etiology and disease course of many brain-based conditions, including multiple sclerosis, Alzheimer’s disease, traumatic brain and spinal cord injury, and brain cancers. In contrast, it is only recently becoming clear that innate immune cells, primarily brain resident macrophages called microglia, are also key regulators of brain development. This review summarizes the current state of knowledge regarding microglia in brain development, with particular emphasis on how microglia during development are distinct from microglia later in life. We also summarize the effects of early life perturbations on microglia function in the developing brain, the role that biological sex plays in microglia function, and the potential role that microglia may play in developmental brain disorders. Finally, given how new the field of developmental neuroimmunology is, we highlight what has yet to be learned about how innate immune cells shape the development of brain and behavior.
- 13 April 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 698
Top Cited PapersOpen AccessMicroglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function
Innate immune cells play a well-documented role in the etiology and disease course of many brain-based conditions, including multiple sclerosis, Alzheimer’s disease, traumatic brain and spinal cord injury, and brain cancers. In contrast, it is only recently becoming clear that innate immune cells, primarily brain resident macrophages called microglia, are also key regulators of brain development. This review summarizes the current state of knowledge regarding microglia in brain development, with particular emphasis on how microglia during development are distinct from microglia later in life. We also summarize the effects of early life perturbations on microglia function in the developing brain, the role that biological sex plays in microglia function, and the potential role that microglia may play in developmental brain disorders. Finally, given how new the field of developmental neuroimmunology is, we highlight what has yet to be learned about how innate immune cells shape the development of brain and behavior.
- 1 August 2017
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 64, 11-22
Sex differences in microglial phagocytosis in the neonatal hippocampus
- 1 August 2017
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 64, 11-22
Sex differences in microglial phagocytosis in the neonatal hippocampus
- 1 January 2017
- Published by Elsevier in Behavioural Brain Research
- Vol. 316, 279-293
Microglia depletion in early life programs persistent changes in social, mood-related, and locomotor behavior in male and female rats
- 1 January 2017
- Published by Elsevier in Behavioural Brain Research
- Vol. 316, 279-293
Microglia depletion in early life programs persistent changes in social, mood-related, and locomotor behavior in male and female rats
- Open Access
- 7 November 2016
- Published by Wiley in Journal of Neuroscience Research
- Vol. 95 (1-2) , 447-461
The immune system as a novel regulator of sex differences in brain and behavioral development
Sexual differentiation of the brain occurs early in life as a result of sex‐typical hormone action and sex chromosome effects. Immunocompetent cells are being recognized as underappreciated regulators of sex differences in brain and behavioral development, including microglia, astrocytes, and possibly other less well studied cell types, including T cells and mast cells. Immunocompetent cells in the brain are responsive to steroid hormones, but their role in sex‐specific brain development is an emerging field of interest. This Review presents a summary of what is currently known about sex differences in the number, morphology, and signaling profile of immune cells in the developing brain and their role in the early‐life programming of sex differences in brain and behavior. We review what is currently known about sex differences in the response to early‐life perturbations, including stress, inflammation, diet, and environmental pollutants. We also discuss how and why understanding sex differences in the developing neuroimmune environment may provide insight into understanding the etiology of several neurodevelopmental disorders. This Review also highlights what remains to be discovered in this emerging field of developmental neuroimmunology and underscores the importance of filling in these knowledge gaps.
- 7 November 2016
- Published by Wiley in Journal of Neuroscience Research
- Vol. 95 (1-2) , 447-461
Open AccessThe immune system as a novel regulator of sex differences in brain and behavioral development
Sexual differentiation of the brain occurs early in life as a result of sex‐typical hormone action and sex chromosome effects. Immunocompetent cells are being recognized as underappreciated regulators of sex differences in brain and behavioral development, including microglia, astrocytes, and possibly other less well studied cell types, including T cells and mast cells. Immunocompetent cells in the brain are responsive to steroid hormones, but their role in sex‐specific brain development is an emerging field of interest. This Review presents a summary of what is currently known about sex differences in the number, morphology, and signaling profile of immune cells in the developing brain and their role in the early‐life programming of sex differences in brain and behavior. We review what is currently known about sex differences in the response to early‐life perturbations, including stress, inflammation, diet, and environmental pollutants. We also discuss how and why understanding sex differences in the developing neuroimmune environment may provide insight into understanding the etiology of several neurodevelopmental disorders. This Review also highlights what remains to be discovered in this emerging field of developmental neuroimmunology and underscores the importance of filling in these knowledge gaps.
- Open Access
- 10 March 2016
- Published by The Endocrine Society in Endocrinology
- Vol. 157 (5) , 2041-2051
Centrally Synthesized Estradiol Is a Potent Anti-Inflammatory in the Injured Zebra Finch Brain
In homeotherms, injury to the brain, such as a penetrating wound, increases microglial cytokine expression and astroglial aromatase (estrogen synthase). In songbirds, injury-induced synthesis of estrogens is neuroprotective as aromatase inhibition and replacement with estradiol (E2) exacerbates and mitigates the extent of damage, respectively. The influence of induced aromatization on inflammation, however, remains unstudied. We hypothesized that injury-induced aromatization, via E2 synthesis, may affect neuroinflammation after a penetrating brain injury. Using adult zebra finches, we first documented an increase in the transcription of cytokines but not aromatase, 2 hours after the injury. Twenty-four hours after the injury, however, aromatase was dramatically elevated and cytokine expression had returned to baseline, suggesting that aromatization may be involved in the decrease of cytokines and neuroinflammation. In two subsequent experiments, we tested the influence of the inhibition of induced aromatization and aromatase inhibition with concomitant central E2 replacement on the transcription of the cytokines TNF-α, IL-1β, and IL-6, the enzyme cyclooxygenase-2 (cox-2), and its product prostaglandin E2 (PGE2). Administration of fadrozole, an aromatase inhibitor, caused a sustained elevation of IL-1β in females and TNF-α, cox-2, and PGE2 in both sexes. This prolonged neuroinflammation appears to be due to a failure to synthesize E2 locally because intracranial E2 replacement lowered IL-1β in females, TNF-α in males, and cox-2 and PGE2 in both sexes. IL-6 was not affected by injury, aromatase inhibition, or E2 replacement in either sex. These data suggest that E2 synthesis after a penetrating brain injury is a potent and inducible anti-inflammatory signal, with specific modulation of discrete cytokine signaling.
- 10 March 2016
- Published by The Endocrine Society in Endocrinology
- Vol. 157 (5) , 2041-2051
Open AccessCentrally Synthesized Estradiol Is a Potent Anti-Inflammatory in the Injured Zebra Finch Brain
In homeotherms, injury to the brain, such as a penetrating wound, increases microglial cytokine expression and astroglial aromatase (estrogen synthase). In songbirds, injury-induced synthesis of estrogens is neuroprotective as aromatase inhibition and replacement with estradiol (E2) exacerbates and mitigates the extent of damage, respectively. The influence of induced aromatization on inflammation, however, remains unstudied. We hypothesized that injury-induced aromatization, via E2 synthesis, may affect neuroinflammation after a penetrating brain injury. Using adult zebra finches, we first documented an increase in the transcription of cytokines but not aromatase, 2 hours after the injury. Twenty-four hours after the injury, however, aromatase was dramatically elevated and cytokine expression had returned to baseline, suggesting that aromatization may be involved in the decrease of cytokines and neuroinflammation. In two subsequent experiments, we tested the influence of the inhibition of induced aromatization and aromatase inhibition with concomitant central E2 replacement on the transcription of the cytokines TNF-α, IL-1β, and IL-6, the enzyme cyclooxygenase-2 (cox-2), and its product prostaglandin E2 (PGE2). Administration of fadrozole, an aromatase inhibitor, caused a sustained elevation of IL-1β in females and TNF-α, cox-2, and PGE2 in both sexes. This prolonged neuroinflammation appears to be due to a failure to synthesize E2 locally because intracranial E2 replacement lowered IL-1β in females, TNF-α in males, and cox-2 and PGE2 in both sexes. IL-6 was not affected by injury, aromatase inhibition, or E2 replacement in either sex. These data suggest that E2 synthesis after a penetrating brain injury is a potent and inducible anti-inflammatory signal, with specific modulation of discrete cytokine signaling.
- 1 February 2016
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 28 (2) , 12348
A Quantification of the Injury‐Induced Changes in Central Aromatase, Oestrogenic Milieu and Steroid Receptor Expression in the Zebra Finch
In songbirds and mammals, brain injury results in the up‐regulation of aromatase (oestrogen synthase) expression in astroglia. The resulting presumed synthesis of neural oestradiol (E2) has neuroprotective effects including a decrease in neurodegeneration, neuroinflammation and apoptosis. The development of therapeutic tools that exploit oestrogenic neuroprotection in the treatment of neurotrauma requires a precise quantification of the endogenous changes in neural aromatase and E2 following brain injury. Surprisingly, the expected increase in neural oestrogens following brain injury has not been demonstrated. Furthermore, we are just beginning to unravel the mechanisms behind the protective effects of centrally synthesised E2. In the present study, levels of aromatase immunoprotein, neural E2 and steroid receptor mRNA were quantified in adult male and female zebra finches 48 h following a unilateral penetrating brain injury. Both aromatase and E2 were up‐regulated in the injured hemisphere of the brain compared to the uninjured hemisphere, demonstrating for the first time a robust increase in neural E2 levels following injury. We did not detect an effect of injury on mRNA expression of the oestrogen receptors (ER)‐α, ER‐β or GPER‐1, but observed a significant decrease in androgen receptor transcription in the injured lobe relative to the contralateral uninjured hemisphere. We conclude that mechanical damage causes a dramatic increase in local aromatisation, and the resultant high levels of central E2 are available to modulate steroid sensitive targets. Studies using alternate methods of receptor detection and/or time points may be necessary to understand the complete suite of mechanisms underlying the neuroprotective effects of induced oestrogen synthesis in this animal model.
- 1 February 2016
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 28 (2) , 12348
A Quantification of the Injury‐Induced Changes in Central Aromatase, Oestrogenic Milieu and Steroid Receptor Expression in the Zebra Finch
In songbirds and mammals, brain injury results in the up‐regulation of aromatase (oestrogen synthase) expression in astroglia. The resulting presumed synthesis of neural oestradiol (E2) has neuroprotective effects including a decrease in neurodegeneration, neuroinflammation and apoptosis. The development of therapeutic tools that exploit oestrogenic neuroprotection in the treatment of neurotrauma requires a precise quantification of the endogenous changes in neural aromatase and E2 following brain injury. Surprisingly, the expected increase in neural oestrogens following brain injury has not been demonstrated. Furthermore, we are just beginning to unravel the mechanisms behind the protective effects of centrally synthesised E2. In the present study, levels of aromatase immunoprotein, neural E2 and steroid receptor mRNA were quantified in adult male and female zebra finches 48 h following a unilateral penetrating brain injury. Both aromatase and E2 were up‐regulated in the injured hemisphere of the brain compared to the uninjured hemisphere, demonstrating for the first time a robust increase in neural E2 levels following injury. We did not detect an effect of injury on mRNA expression of the oestrogen receptors (ER)‐α, ER‐β or GPER‐1, but observed a significant decrease in androgen receptor transcription in the injured lobe relative to the contralateral uninjured hemisphere. We conclude that mechanical damage causes a dramatic increase in local aromatisation, and the resultant high levels of central E2 are available to modulate steroid sensitive targets. Studies using alternate methods of receptor detection and/or time points may be necessary to understand the complete suite of mechanisms underlying the neuroprotective effects of induced oestrogen synthesis in this animal model.